Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

Published: 09 December 2023
on channel: PBS NewsHour

9,935

198

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: / newshour
Instagram: / newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe

Watch video Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’ online without registration, duration hours minute second in high quality. This video was added by user PBS NewsHour 09 December 2023, don't forget to share it with your friends and acquaintances, it has been viewed on our site 9,935 once and liked it 198 people.